Back
Spero Therapeutics Stock Price Chart
Sponsored
SPRO
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
9
SPRO
Spero Therapeutics
Last Price:
$0.94
Seasonality Move:
10.44%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPRO is experiencing slight selling pressure.
Spero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.98 | Sell |
20-day SMA: | 1.08 | Sell |
50-day SMA: | 1.18 | Sell |
200-day SMA: | 1.38 | Sell |
8-day EMA: | 0.98 | Sell |
20-day EMA: | 1.06 | Sell |
50-day EMA: | 1.15 | Sell |
200-day EMA: | 1.32 | Sell |
Spero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 25.68 | Sell |
Chaikin Money Flow: | 98582 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.01 - 1.19) | Sell |
Bollinger Bands (100): | (1.13 - 1.35) | Sell |
Spero Therapeutics Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Spero Therapeutics Stock
Is Spero Therapeutics Stock a Buy?
-
Spero Therapeutics share price is 0.94 while SPRO 8-day simple moving average is 0.98, which is a Sell signal.
-
The stock price of SPRO is 0.94 while Spero Therapeutics 20-day SMA is 1.08, which makes it a Sell.
-
Spero Therapeutics 50-day simple moving average is 1.18 while SPRO share price is 0.94, making it a Sell technically.
-
SPRO stock price is 0.94 and Spero Therapeutics 200-day simple moving average is 1.38, creating a Sell signal.
SPRO Technical Analysis vs Fundamental Analysis
Sell
9
Spero Therapeutics (SPRO)
is a Sell
Is Spero Therapeutics a Buy or a Sell?
-
Spero Therapeutics stock is rated a SellThe current Spero Therapeutics [SPRO] share price is $0.94. The Score for SPRO is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
Spero Therapeutics Stock Info
Market Cap:
51.5M
Price in USD:
0.94
Share Volume:
494.7K
Spero Therapeutics 52-Week Range
52-Week High:
1.89
52-Week Low:
0.92
Sell
9
Spero Therapeutics (SPRO)
is a Sell
Spero Therapeutics Share Price Forecast
-
What is the Spero Therapeutics stock price today?The Spero Therapeutics stock price is 0.94 USD today.
-
Will SPRO stock go up or go down?Spero Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Spero Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spero Therapeutics is overvalued.
Is Spero Therapeutics Stock a Buy?
-
Spero Therapeutics share price is 0.94 while SPRO 8-day exponential moving average is 0.98, which is a Sell signal.
-
The stock price of SPRO is 0.94 while Spero Therapeutics 20-day EMA is 1.06, which makes it a Sell.
-
Spero Therapeutics 50-day exponential moving average is 1.15 while SPRO share price is 0.94, making it a Sell technically.
-
SPRO stock price is 0.94 and Spero Therapeutics 200-day simple moving average is 1.32, creating a Sell signal.
Fundamental Analysis of Spero Therapeutics
Is Spero Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and an increase next year of $0.38 per share.
Technical Analysis of Spero Therapeutics
Should I short Spero Therapeutics stock?
-
SPRO Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Spero Therapeutics is a Sell
-
Spero Therapeutics Relative Strength Index (RSI) is 25.68, which suggest Spero Therapeutics is oversold
-
The Bollinger Bands (25) for Spero Therapeutics is (1.01 - 1.19), which suggest Spero Therapeutics is a Sell
-
The Bollinger Bands (100) for Spero Therapeutics is (1.13 - 1.35), which suggest Spero Therapeutics is a Sell
* Spero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.